BSE filing, NSE: INTEGFD. Summary written from the filing by ALFA Finder's alert engine.
Integrated Proteins Ltd: key numbers
- Share price
- ₹13.65
- Market cap
- ₹255.4 Cr
- Revenue (annual)
- ₹9.94 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 406.2×Sector 38.3×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integrated Proteins Ltd
All →Integrated Proteins Other Announcement
Integrated Proteins Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Integrated Proteins Management Change
Integrated Proteins Limited appointed Sandeep Mahadik as Non-Executive Independent Director and Ankita Shah as Secretarial Auditor, both effective September 30, 2026.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd held its Annual General Meeting on September 30, 2026. Shareholders considered resolutions regarding financial statements and company appointments.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.
Integrated Proteins Annual Report
Integrated Proteins Limited has released its 33rd Annual Report for the financial year 2025-26, containing financial statements and details for the upcoming annual general meeting.
Integrated Proteins Capital Structure Change
Integrated Proteins Limited has been assigned a new ISIN, INE177M01021, following a stock split. The change is effective from September 4, 2026.
Other management change announcements
All →Suraj Management Change
Suraj Limited appointed Mr. Mayank Balvantbhai Rami as Company Secretary and Compliance Officer effective November 1, 2026. The board approved this KMP appointment on October 29, 2026.
Superior Finlease Management Change
Superior Finlease disclosed that Mr. Krishan Gopal Sharma resigned as CFO and KMP effective 28 Oct 2026 due to personal commitments. No successor is named yet.
Vertex Securities Management Change
Vertex Securities appointed Ms. Unni as Independent Director and Mr. Iyer as CFO, effective October 2026. Both roles were approved at the 28 October board meeting.
Kirloskar Brothers Management Change
Kirloskar Brothers' Independent Directors Vivek Pendharkar and Rekha Sethi completed their 5-year terms on 28 Oct 2026. They ceased from the Board and all committees.
iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.